NANOVIRICIDES, INC: SUFFICIENT QUANTITY OF NV-387 ORAL GUMMIES DRUG PRODUCT FOR STARTING CLINICAL TRIAL AGAINST EBOLA IS ALREADY AVAILABLE IN DRC

Reuters · 3d ago

Please log in to view news